Oxidative stress in Crohn's disease;Estrés oxidativo en la enfermedad de Crohn

Gastroenterologia y Hepatologia

Volumn 37, Issue 1, 2014, Pages 28-34

  Moret, Inés ^a,b   Cerrillo, Elena ^a   Navarro Puche, Ana ^a   Iborra, Marisa ^a,b   Rausell, Francisco ^a,b   Tortosa, Luis ^a,b   Beltrán, Belén ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Catalase; Crohn's disease; Oxidative stress

Indexed keywords

REACTIVE OXYGEN METABOLITE; ANTIINFLAMMATORY AGENT; AUTOANTIBODY; CATALASE; HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; LEUKOTRIENE B4; NOS2 PROTEIN, HUMAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROBIOTIC AGENT; REACTIVE NITROGEN SPECIES; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ARTICLE; BLOOD; CROHN DISEASE; HUMAN; IMMUNE RESPONSE; INTESTINE MUCOSA; OXIDATIVE STRESS; AGONISTS; BIOSYNTHESIS; IMMUNOLOGY; INFLAMMATION; LYMPHOCYTE; METABOLISM; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY;

ANTI-INFLAMMATORY AGENTS; AUTOANTIBODIES; CATALASE; CROHN DISEASE; HUMANS; HYDROGEN PEROXIDE; INFLAMMATION; INTESTINAL MUCOSA; LEUKOTRIENE B4; LYMPHOCYTES; NADPH OXIDASE; NEUTROPHILS; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PPAR GAMMA; PROBIOTICS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84892551535     PISSN: 02105705     EISSN: 15789519     Source Type: Journal    
DOI: 10.1016/j.gastrohep.2013.01.008     Document Type: Article

References (56)

1. Xavier R.J., Podolsky D.K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007, 448:427-434.
2. Packey C.D., Sartor R.B. Interplay of commensal and pathogenic bacteria, genetic mutations, and immunoregulatory defects in the pathogenesis of inflammatory bowel diseases. J Intern Med 2008, 263:597-606.
3. Kruidenier L., Kuiper I., Lamers C.B., Verspaget H.W. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants. J Pathol 2003, 201:28-36.
4. Kruidenier L., Kuiper I., van Duijn W., Mieremet-Ooms M.A., van Hogezand R.A., Lamers C.B., et al. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease. J Pathol 2003, 201:17-27.
5. Rezaie A., Parker R.D., Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause. Dig Dis Sci 2007, 52:2015-2021.
6. Tüzün A., Erdil A., Inal V., Aydin A., Baǧci S., Yeşilova Z., et al. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem 2002, 35:569-572.
7. Rezaie A., Ghorbani F., Eshghtork A., Zamani M.J., Dehghan G., Taghavi B., et al. Alterations in salivary antioxidants, nitric oxide, and transforming growth factor-beta 1 in relation to disease activity in Crohn's disease patients. Ann N Y Acad Sci 2006, 1091:110-122.
8. Simmonds N.J., Allen R.E., Stevens T.R., van Someren R.N., Blake D.R., Rampton D.S. Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease. Gastroenterology 1992, 103:186-196.
9. Lih-Brody L., Powell S.R., Collier K.P., Reddy G.M., Cerchia R., Kahn E., et al. Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996, 41:2078-2086.
10. Zhu H., Li R. Oxidative stress and redox signaling mechanisms of inflammatory bowel disease: updated experimental and clinical evidence. Exp Biol Med 2012, 237:474-480.
11. Chen J.J., Bertrand H., Yu B.P. Inhibition of adenine nucleotide translocator by lipid peroxidation products. Free Radic Biol Med 1995, 19:583-590.
12. Dean R.T., Fu S., Stocker R., Davies M.J. Biochemistry and pathology of radical mediated protein oxidation. Biochem J 1997, 324:1-18.
13. Krzystek-Korpacka M., Neubauer K., Berdowska I., Boehm D., Zielinski B., Petryszyn P., et al. Enhanced Formation of Advanced Oxidation Protein Products in IBD. Inflamm Bowel Dis 2008, 14:794-802.
14. Kruidenier L., Verspaget H.W. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease-radicals or ridiculous. Aliment Pharmacol Ther 2002, 16:1997-2015.
15. Cathcart R., Schwiers E., Saul R.L., Ames B.N. Thymine glycol and thymidine glycol in human and rat urine: a possible assay for oxidative DNA damage. PNAS 1984, 81:5633-5637.
16. Shigenaga M.K., Gimeno C.J. Ames BN. Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. PNAS 1989, 86:9697-9701.
17. Gutteridge J.M. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995, 41:1819-1828.
18. Jefferies H., Coster J., Khalil A., Bot J., McCauley R.D., Hall J.C. Glutathione. ANZ J Surg 2003, 73:517-522.
19. Bernard D., Quatannens B., Begue A., Vandenbunder B., Abbadie C. Antiproliferative and antiapoptotic effects of cRel may occur within the same cells via the up-regulation of manganese superoxide dismutase. Cancer Res 2001, 61:2656-2664.
20. Chovolou Y., Watjen W., Kampkotter A., Kahl R. Resistance to Tumor Necrosis Factor-α (TNF-α)-induced apoptosis in rat hepatoma cells expressing TNF-α is linked to low antioxidant enzyme expression. J Biol Chem 2003, 278:29626-29632.
21. Herrlich B., Bohmer F.D. Redox regulation of signal transducion in mammalian cells. Biochem Pharmacol 2000, 59:35-41.
22. Iborra M., Moret I., Rausell F., Bastida G., Aguas M., Cerrillo E., et al. Role of oxidative stress and antioxidant enzymes in Crohn's disease. Biochem Soc Trans 2011, 39:1102-1106.
23. Beltrán B., Nos P., Dasí F., Iborra M., Bastida G., Martínez M., et al. Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of naïve and treated Crohn's disease. Inflamm Bowel Dis 2010, 16:76-86.
24. Biagioni C., Favilli F., Catarzi S., Marcucci T., Fazi M., Tonelli F., et al. Redox state and 02- production in neutrophils of Crohn's disease patients. Exp Biol Med 2006, 231:186-195.
25. Russo I, Luciani A, De Cicco P, Troncone E, Ciacci C. Butyrate attenuates lipopolysaccharide-induced inflammation in intestinal cells and Crohn's mucosa through modulation of antioxidant defense machinery. PLoS One. 2012;7:e32841.
26. Gloire G., Legrand-Poels S., Piette J. NF-kappa B activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006, 72:1493-1505.
27. Rumley A.G., Paterson J.R. Analytical aspects of antioxidants and free radical activity in clinical biochemistry. Ann Clin Biochem 1998, 35:181-200.
28. Chiarpotto E., Scavazza A., Leonarduzzi G., Camandola S., Biasi F., Teggia P.M., et al. Oxidative damage and transforming growth fector beta 1 in pretumoral and tumoral lesions of human intestine. Free Rad Biol Med 1997, 22:889-894.
29. Sedghi S., Keshavarzian A., Klamut M., Eiznhamer D., Zarling E.J. Elevated breath ethane levels in active ulcerative colitis: evidence for excessive lipid peroxidation. Am J Grastroenterol 1994, 89:2217-2221.
30. Chevion M., Berenshtein E., Stadtman E.R. Human studies related to protein oxidation: protein carbonyl content as a marker os damage. Free Rad Res 2000, 33:S99-S108.
31. Singer I.I., Kawka D.W., Scott S., Weidner J.R., Mumford R.A., Riehl T.E., et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996, 111:871-885.
32. Lih-Brody L., Powell S.R., Collier K.P., Reddy G.M., Cerchia R., Kahn E., et al. Increased oxidative stress and decresased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996, 41:2078-2086.
33. Almenier H.A., Al Menshawy H.H., Maher M.M., Al Gamal S. Oxidative stress and inflammatory bowel disease. Front Biosci (Elite Ed) 2012, 4:1335-1344.
34. Oudkerk Pool M., Bouma G., Visser J.J., Kolkman J.J., Tran D.D., Meuwissen S.G., et al. Serum nitrate levels in ulcerative colitis and Crohn's disease. Scand J Gastroenterol 1995, 30:784-788.
35. Harris M.L., Schiller H.J., Reilly P.M., Donowitz M., Grisham M.B., Bulkley G.B. Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: cause, consequence or epiphenomenonα. Pharmacol Ther 1992, 53:375-408.
36. Alayash A.I., Patel R.P., Cashon R.E. Redox reactions of hemoglobin and myoglobin: biological and toxicological implications. Antioxid Redox Signal 2001, 3:313-327.
37. Jourd'Heuil D., Mills L., Miles A.M., Grisham M.B. Effect of nitric oxide on hemoprotein-catalyzed oxidative reactions. Nitric Oxide 1998, 2:37-44.
38. Pavlick K.P., Laroux F.S., Fuseler J., Wolf R.E., Gray L., Hoffman J., et al. Role of reactive metabolites of oxygen and nitrogen in inflammatory bowel disease. Free Radic Biol Med 2002, 33:311-322.
39. Segain J.P., Raingeard de la Blétière D., Bourreille A., Leray V., Gervois N., Rosales C., et al. Butyrate inhibits inflammatory responses through NF-kappa B inhibition: implications for Crohn's disease. Gut 2000, 47:397-403.
40. Kinoshita M., Suzuki Y., Saito Y. Butyrate reduces colonic paracellular permeability by enhancing PPAR gamma activation. Biochem Biophys Res Commun 2000, 293:827-831.
41. Poynter M.E., Daynes R.A. Peroxisome Proliferator-activated Receptor alpha activation modulates cellular redox status, reperesses nuclear factor-kB signaling and reduces inflammatory cytokine production in aging. J Biol Chem 1998, 273:32833-32841.
42. Okuno Y., Matsuda M., Miyata Y., Fukuhara A., Komuro R., Shimabukuro M., et al. Human catalase gene is regulated by peroxisome proliferator activated receptor through a response element distinc from that of mouse. Endocr J 2010, 57:303-309.
43. D'Odorico A., Bortolan S., Cardin R., D'Inca' R., Martines D., Ferronato A., et al. Reduced plasma antioxidant concentrations and increased oxidative DNA damage in inflammatory bowel disease. Scand J Gastroenterol 2001, 36:1289-1294.
44. Boehm D., Krzystek-Korpacka M., Neubauer K., Matusiewicz M., Berdowska I., Zielinski B., et al. Paraoxonase-1 status in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2009, 15:93-99.
45. Koutroubakis I.E., Malliaraki N., Dimoulios P.D., Karmiris K., Castanas E., Kouroumalis E.A. Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease. Dig Dis Sci 2004, 49:1433-1437.
46. Maor I., Rainis T., Lanir A., Lavy A. Oxidative stress, inflammation and neutrophil superoxide release in patients with Crohn's disease: distinction between active and non-active disease. Dig Dis Sci 2008, 53:2208-2214.
47. Akman T., Akarsu M., Akpinar H., Resmi H., Sezer E. Erythrocyte deformability and oxidative stress in inflammatory bowel disease. Dig Dis Sci 2012, 57:464-548.
48. Krzystek-Korpacka M., Neubauer K., Berdowska I., Zielinski B., Paradowski L., Gamian A. Impaired erythrocyte antioxidant defense in activeinflammatory bowel disease: impact of anemia and treatment. Inflamm Bowel Dis 2010, 16:1467-1475.
49. Dincer Y., Erzin Y., Himmetoglu S., Gunes K.N., Bal K., Akcay T. Oxidative DNA damage and antioxidant activity in patients with inflammatory bowel disease. Dig Dis Sci 2007, 52:1636-1641.
50. Yasmineh W.G., Theologides A. Catalase as a roving scavenger of hydrogen peroxide: a hypothesis. J Lab Clin Med 1993, 122:110-114.
51. Rush J.W., Sandiford S.D. Plasma glutathione peroxidase in healthy young adults: influence of gender and physical activity. Clin Biochem 2003, 36:345-351.
52. Zelko I.N., Mariani T.J., Folz R.J. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002, 33:337-349.
53. Pena L.R., Hill D.B., McClain C.J. Treatment with glutathione precursor decreases cytokine activity. J Parenter Enteral Nutr 1999, 23:1-6.
54. Kitahora T., Suzuki K., Asakura H., Yoshida T., Suematsu M., Watanabe M., et al. Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn's disease. Dig Dis Sci 1988, 33:951-955.
55. Moret I., Rausell F., Iborra M., Bastida G., Aguas M., Tortosa L., et al. Apoptosis resistance of Crohn's disease blood T-cells depends on catalase activity inhibition. Gastroenterology 2012, 142:885.
56. Kim H., Kim Y.N., Kim H., Kim C.W. Oxidative stress attenuates Fas-mediated apoptosis in Jurkat T cell line through Bfl-1 induction. Oncogene 2005, 24:1252-1261.